NORTH AMERICA MULTIPLEX ASSAY MARKET FORECAST 2019-2027

  • You are here:
  • Home
  • Reports
  • NORTH AMERICA MULTIPLEX ASSAY MARKET FORECAST 2019-2027

NORTH AMERICA MULTIPLEX ASSAY MARKET FORECAST 2019-2027

The North American region for the market of the multiplex assay is predicted to record a CAGR of 6.21% during the projected period of 2019-2027. The factors driving the market growth are the enormous scope in the field of research and development in the treatment of diseases like cancer and heart diseases, increase in government funding, the preference of multiple assay over traditional assays which are time consuming, comprehensive use in the production of personalized medicines which are accurate for individual patient. The region of America is divided into the region of the US and Canada, with respect to the multiplex assay market. The US is dominating the multiplex assay market due to an increase in the demand in the pharmaceutical industry. However, it is expected that the market in Canada will witness maximum growth during the forecast period. The focus of the key players in the market is on launches of new products and approval.

NORTH AMERICA MULTIPLEX ASSAY MARKET FORECAST 2019-2027

Request free sample

The North American region for the market of the multiplex assay is predicted to record a CAGR of 6.21% during the projected period of 2019-2027. The factors driving the market growth are the enormous scope in the field of research and development in the treatment of diseases like cancer and heart diseases, increase in government funding, the preference of multiple assay over traditional assays which are time consuming, comprehensive use in the production of personalized medicines which are accurate for individual patient.

The region of America is divided into the region of the US and Canada, with respect to the multiplex assay market. The US is dominating the multiplex assay market due to an increase in the demand in the pharmaceutical industry. However, it is expected that the market in Canada will witness maximum growth during the forecast period. The focus of the key players in the market is on launches of new products and approval. The driving factor in the US market is the supportive initiatives by the government to develop precision medicine, along with strategic partners between key players competing for multiplex assay development. As part of the precision medicine initiative, the US government proposed funds to develop precision medicine to treat diseases and improve health. The government also took a new initiative to enhance biomedical research to develop new drugs, treatments, and therapies, and also improve health outcomes. Multiplex assay tests are used to determine specific mutations to explain the causes of the disease, and develop drugs and therapies for treatment.

There are many key players present in the organized market of the multiplex assay. Agilent Technologies, Inc. is a company that offers software, reagents, instruments, to applied chemical, life sciences, and diagnostics market. The company has its headquarters in Santa Clara, California.

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

    1. RESEARCH SCOPE
      • STUDY GOALS
      • SCOPE OF THE MARKET STUDY
      • WHO WILL FIND THIS REPORT USEFUL?
      • STUDY AND FORECASTING YEARS
    2. RESEARCH METHODOLOGY
      • SOURCES OF DATA
        • SECONDARY DATA
        • PRIMARY DATA
      • TOP-DOWN APPROACH
      • BOTTOM-UP APPROACH
      • DATA TRIANGULATION
    3. EXECUTIVE SUMMARY
      • MARKET SUMMARY
      • KEY FINDINGS
        • NUCLEIC ACID-BASED MULTIPLEX ASSAYS ARE THE FASTEST GROWING TYPE
        • REAGENTS AND CONSUMABLES ARE THE WIDELY USED PRODUCTS
        • MULTIPLEX PCR IS THE HIGHLY DEMANDED MULTIPLEX ASSAY TECHNOLOGY
        • MULTIPLEX ASSAYS ARE HIGHLY ECONOMICAL
    1. MARKET DYNAMICS
      • MARKET SCOPE & DEFINITION
      • MARKET DRIVERS
        • GROWING R&D ACTIVITIES & GOVERNMENTAL FUNDING
        • PREFERENCE OF MULTIPLEX ASSAYS OVER CONVENTIONAL ASSAYS
        • INCREASED ADOPTION OF PERSONALIZED MEDICINES
      • MARKET RESTRAINTS
        • LACK OF SKILLED PROFESSIONALS
      • MARKET OPPORTUNITIES
        • GROWING OPPORTUNITIES IN THE EMERGING ECONOMIES
        • IDENTIFICATION OF NOVEL BIOMARKERS
      • MARKET CHALLENGES
        • STRINGENT REGULATIONS
    1. MARKET BY TYPE
      • PROTEIN-BASED MULTIPLEX ASSAYS
      • NUCLEIC ACID-BASED MULTIPLEX ASSAYS
      • OTHER MULTIPLEX ASSAYS
    2. MARKET BY PRODUCT
      • REAGENTS AND CONSUMABLES
      • INSTRUMENTS AND ACCESSORIES
      • SOFTWARE AND SERVICES
    3. MARKET BY TECHNOLOGY
      • MULTIPLEX PROTEIN MICROARRAY
      • MULTIPLEX PCR
      • OTHER TECHNOLOGY
    4. MARKET BY APPLICATION
      • CLINICAL DIAGNOSTICS
      • RESEARCH AND DEVELOPMENT
      • COMPANION DIAGNOSTICS
    5. MARKET BY END-USER
      • HOSPITALS
      • CLINICAL LABORATORIES
      • RESEARCH INSTITUTES
      • PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    6. KEY ANALYTICS
      • PORTER’S FIVE FORCES MODEL
        • THREAT OF NEW ENTRANTS
        • THREAT OF SUBSTITUTE PRODUCTS
        • BARGAINING POWER OF BUYER
        • BARGAINING POWER OF SUPPLIER
        • INTENSITY OF COMPETITIVE RIVALRY
      • KEY BUYING CRITERIA
      • KEY TRENDS
      • OPPORTUNITY MATRIX
    7. GEOGRAPHICAL ANALYSIS
      • NORTH AMERICA
        • THE UNITED STATES
        • CANADA
    1. COMPETITIVE LANDSCAPE
      • MARKET SHARE ANALYSIS
      • COMPANY PROFILES
        • ABCAM PLC.
        • AGILENT TECHNOLOGIES, INC.
        • BECTON DICKINSON AND COMPANY
        • BIO-RAD LABORATORIES, INC.
        • BIO-TECHNE CORPORATION
        • ILLUMINA, INC
        • LUMINEX CORPORATION
        • MERCK MILIPORE
        • MESO SCALE DIAGNOSTICS, LLC
        • OLINK PROTEOMICS AB
        • QIAGEN N.V.
        • RANDOX LABORATORIES LTD.
        • SEEGENE INC.
        • SIEMENS HEALTHINEERS
        • THERMO FISHER SCIENTIFIC INC.

LIST OF TABLES

TABLE 1: NORTH AMERICA MULTIPLEX ASSAY MARKET, 2019-2027 ($ MILLION)

TABLE 2: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY TYPE, 2019-2027 ($ MILLION)

TABLE 3: NORTH AMERICA PROTEIN-BASED MULTIPLEX ASSAYS MARKET, 2019-2027 ($ MILLION)

TABLE 4: NORTH AMERICA NUCLEIC ACID-BASED MULTIPLEX ASSAYS MARKET, 2019-2027 ($ MILLION)

TABLE 5: NORTH AMERICA OTHER MULTIPLEX ASSAYS MARKET, 2019-2027 ($ MILLION)

TABLE 6: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY PRODUCT, 2019-2027 ($ MILLION)

TABLE 7: NORTH AMERICA REAGENTS AND CONSUMABLES MARKET, 2019-2027 ($ MILLION)

TABLE 8: NORTH AMERICA INSTRUMENTS AND ACCESSORIES MARKET, 2019-2027 ($ MILLION)

TABLE 9: NORTH AMERICA SOFTWARE AND SERVICES MARKET, 2019-2027 ($ MILLION)

TABLE 10: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, 2019-2027 ($ MILLION)

TABLE 11: NORTH AMERICA MULTIPLEX PROTEIN MICROARRAY MARKET, 2019-2027 ($ MILLION)

TABLE 12: NORTH AMERICA MULTIPLEX PCR MARKET, 2019-2027 ($ MILLION)

TABLE 13: NORTH AMERICA OTHER TECHNOLOGY MARKET, 2019-2027 ($ MILLION)

TABLE 14: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2019-2027 ($ MILLION)

TABLE 15: NORTH AMERICA CLINICAL DIAGNOSTICS MARKET, 2019-2027 ($ MILLION)

TABLE 16: NORTH AMERICA RESEARCH AND DEVELOPMENT MARKET, 2019-2027 ($ MILLION)

TABLE 17: NORTH AMERICA COMPANION DIAGNOSTICS MARKET, 2019-2027 ($ MILLION)

TABLE 18: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY END-USER, 2019-2027 ($ MILLION)

TABLE 19: NORTH AMERICA HOSPITALS MARKET, 2019-2027 ($ MILLION)

TABLE 20: NORTH AMERICA CLINICAL LABORATORIES MARKET, 2019-2027 ($ MILLION)

TABLE 21: NORTH AMERICA RESEARCH INSTITUTES MARKET, 2019-2027 ($ MILLION)

TABLE 22: NORTH AMERICA PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET, 2019-2027 ($ MILLION)

TABLE 23: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY COUNTRY, 2019-2027 ($ MILLION)

TABLE 24: THE UNITED STATES MULTIPLEX ASSAY MARKET, BY TYPE, 2019-2027 ($ MILLION)

TABLE 25: THE UNITED STATES MULTIPLEX ASSAY MARKET, BY PRODUCT, 2019-2027 ($ MILLION)

TABLE 26: THE UNITED STATES MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, 2019-2027 ($ MILLION)

TABLE 27: THE UNITED STATES MULTIPLEX ASSAY MARKET, BY APPLICATION, 2019-2027 ($ MILLION)

TABLE 28: THE UNITED STATES MULTIPLEX ASSAY MARKET, BY END-USER, 2019-2027 ($ MILLION)

TABLE 29: CANADA MULTIPLEX ASSAY MARKET, BY TYPE, 2019-2027 ($ MILLION)

TABLE 30: CANADA MULTIPLEX ASSAY MARKET, BY PRODUCT, 2019-2027 ($ MILLION)

TABLE 31: CANADA MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, 2019-2027 ($ MILLION)

TABLE 32: CANADA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2019-2027 ($ MILLION)

TABLE 33: CANADA MULTIPLEX ASSAY MARKET, BY END-USER, 2019-2027 ($ MILLION)

LIST OF FIGURES

FIGURE 1: NORTH AMERICA MULTIPLEX ASSAY MARKET, 2019-2027 ($ MILLION)

FIGURE 2: NORTH AMERICA MULTIPLEX ASSAY MARKET SHARE, BY TYPE, 2018 & 2027 (%)

FIGURE 3: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY PROTEIN-BASED MULTIPLEX ASSAYS, 2019-2027 ($ MILLION)

FIGURE 4: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY NUCLEIC ACID-BASED MULTIPLEX ASSAYS, 2019-2027 ($ MILLION)

FIGURE 5: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY OTHER MULTIPLEX ASSAYS, 2019-2027 ($ MILLION)

FIGURE 6: NORTH AMERICA MULTIPLEX ASSAY MARKET SHARE, BY PRODUCT, 2018 & 2027 (%)

FIGURE 7: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY REAGENTS AND CONSUMABLES, 2019-2027 ($ MILLION)

FIGURE 8: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY INSTRUMENTS AND ACCESSORIES, 2019-2027 ($ MILLION)

FIGURE 9: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY SOFTWARE AND SERVICES, 2019-2027 ($ MILLION)

FIGURE 10: NORTH AMERICA MULTIPLEX ASSAY MARKET SHARE, BY TECHNOLOGY, 2018 & 2027 (%)

FIGURE 11: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY MULTIPLEX PROTEIN MICROARRAY, 2019-2027 ($ MILLION)

FIGURE 12: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY MULTIPLEX PCR, 2019-2027 ($ MILLION)

FIGURE 13: ADVANTAGES OF IMMUNOHISTOCHEMISTRY (IHC)

FIGURE 14: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY OTHER TECHNOLOGY, 2019-2027 ($ MILLION)

FIGURE 15: NORTH AMERICA MULTIPLEX ASSAY MARKET SHARE, BY APPLICATION, 2018 & 2027 (%)

FIGURE 16: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY CLINICAL DIAGNOSTICS, 2019-2027 ($ MILLION)

FIGURE 17: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY RESEARCH AND DEVELOPMENT, 2019-2027 ($ MILLION)

FIGURE 18: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY COMPANION DIAGNOSTICS, 2019-2027 ($ MILLION)

FIGURE 19: NORTH AMERICA MULTIPLEX ASSAY MARKET SHARE, BY END-USER, 2018 & 2027 (%)

FIGURE 20: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY HOSPITALS, 2019-2027 ($ MILLION)

FIGURE 21: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY CLINICAL LABORATORIES, 2019-2027 ($ MILLION)

FIGURE 22: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY RESEARCH INSTITUTES, 2019-2027 ($ MILLION)

FIGURE 23: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2019-2027 ($ MILLION)

FIGURE 24: PORTER’S FIVE FORCE MODEL

FIGURE 25: KEY BUYING CRITERIA

FIGURE 26: NEWLY REGISTERED CLINICAL TRIAL STUDY 2016-2018

FIGURE 27: THE UNITED STATES MULTIPLEX ASSAY MARKET, 2019-2027 ($ MILLION)

FIGURE 28: CANADA MULTIPLEX ASSAY MARKET, 2019-2027 ($ MILLION)

FIGURE 29: MULTIPLEX ASSAY COMPANY MARKET SHARE ANALYSIS 2018 (%)

  1. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • THE UNITED STATES
      • CANADA
  1. MARKET BY TYPE
    • PROTEIN-BASED MULTIPLEX ASSAYS
    • NUCLEIC ACID-BASED MULTIPLEX ASSAYS
    • OTHER MULTIPLEX ASSAYS
  2. MARKET BY PRODUCT
    • REAGENTS AND CONSUMABLES
    • INSTRUMENTS AND ACCESSORIES
    • SOFTWARE AND SERVICES
  3. MARKET BY TECHNOLOGY
    • MULTIPLEX PROTEIN MICROARRAY
    • MULTIPLEX PCR
    • OTHER TECHNOLOGY
  4. MARKET BY APPLICATION
    • CLINICAL DIAGNOSTICS
    • RESEARCH AND DEVELOPMENT
    • COMPANION DIAGNOSTICS
  5. MARKET BY END-USER
    • HOSPITALS
    • CLINICAL LABORATORIES
    • RESEARCH INSTITUTES
    • PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES

To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now